ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

3 links0 made here, not in the record6 judgments2 judges (our rules as one)0 record changes seen
Claude Opus 5.5Our rules
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07796477A Study of SYH2069Injection in ParticipantsWith T2DM Not ControlledWith Diet/Exercise Alone orMetforminCSPC Ouyi Pharmaceutical Co., Phase 2 · not yet recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSDiabetes Mellitus, Type 2The registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termAs of now · Our main-condition rule (R9) · Main conditionMain conditionDRUGSSYH2069Entry “SYH2069 Injection (group 1)”, …›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Our role rule · TestedTestedTirzepatideEntry “Tirzepatide Injection 15mg”, r…›Nov 2 · Claude Opus 5.5 · ComparatorNov 18 · Our role rule · ComparatorComparator

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

SYH2069

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “SYH2069 Injection (group 1)”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2SYH2069Claude Opus 5.5TestedCurrent
Nov 2TirzepatideClaude Opus 5.5ComparatorCurrent
Nov 14Diabetes Mellitus, Type 2Our condition-kind ruleFinest filed termCurrent
Nov 18SYH2069Our role ruleTestedAgrees
Nov 18TirzepatideOur role ruleComparatorAgrees
As of nowDiabetes Mellitus, Type 2Our main-condition rule (R9)Main conditionCurrent